Financial Performance - Total revenue for Q3 2023 was approximately CNY 477.90 million, a decrease of 43.24% compared to the same period last year[6] - Net profit attributable to shareholders for Q3 2023 was approximately CNY 81.29 million, down 26.51% year-on-year[6] - Basic earnings per share for Q3 2023 was CNY 0.1455, a decline of 39.26% compared to the previous year[7] - Revenue for the third quarter decreased by 43.24% primarily due to a reduction in export income[13] - Net profit attributable to shareholders, excluding non-recurring gains and losses, fell by 91.24% in the current period[13] - Basic and diluted earnings per share decreased by 39.26% due to an increase in share capital from a private placement[13] - Net profit for the third quarter of 2023 was CNY 244,370,463.33, a decline of 19% from CNY 302,217,506.89 in the same quarter of 2022[24] - Earnings per share for the third quarter of 2023 were CNY 0.4460, compared to CNY 0.6364 in the same quarter of 2022, representing a decrease of approximately 30%[24] Assets and Liabilities - Total assets as of the end of Q3 2023 were approximately CNY 4.26 billion, an increase of 8.63% from the end of the previous year[7] - Total assets reached CNY 4,264,145,267.12 by the end of the third quarter of 2023, compared to CNY 3,925,429,646.80 at the end of the previous year, reflecting an increase of approximately 9%[22] - Total liabilities as of the end of the third quarter of 2023 amounted to CNY 1,151,897,923.09, down from CNY 1,732,031,231.59 at the end of the previous year[22] - Total equity increased to CNY 3,112,247,344.03 in the third quarter of 2023, compared to CNY 2,193,398,415.21 in the same period of 2022, marking an increase of approximately 42%[22] Cash Flow - The net cash flow from operating activities for the year-to-date was approximately CNY 374.59 million, a significant increase of 190.66% compared to the same period last year[6] - Cash inflow from operating activities for the first three quarters of 2023 was $1,632,409,040.39, a decrease of 8.45% compared to $1,783,878,658.54 in the same period of 2022[26] - Net cash flow from operating activities in Q3 2023 was $374,594,596.57, significantly up from $128,879,238.93 in Q3 2022, representing an increase of 190.06%[27] - Total cash inflow from financing activities in Q3 2023 was $729,806,907.29, slightly down from $742,625,771.08 in Q3 2022[28] - Net cash flow from financing activities in Q3 2023 was $411,190,882.19, compared to $93,626,136.52 in Q3 2022, marking an increase of 338.06%[28] - The total cash and cash equivalents at the end of Q3 2023 reached $1,246,707,415.67, up from $491,268,880.80 at the end of Q3 2022, indicating a growth of 153.73%[28] Shareholder Information - The number of common shareholders at the end of the reporting period was 28,927[15] - The largest shareholder, Hunan Haili High-tech Industry Group Co., Ltd., holds 23.50% of the shares[15] Other Financial Metrics - Non-recurring gains and losses for Q3 2023 totaled approximately CNY 71.63 million, with a year-to-date total of CNY 76.85 million[12] - The weighted average return on net assets for Q3 2023 was 2.77%, a decrease of 2.90 percentage points compared to the previous year[7] - The company reported a decrease in total equity attributable to shareholders by 45.53% compared to the previous year[7] - The company reported a significant increase in other income, which rose to CNY 9,076,393.56 from CNY 6,795,950.03 year-over-year[23] - Research and development expenses for the first three quarters of 2023 were CNY 85,971,021.70, down from CNY 94,431,376.66 in the same period of 2022, indicating a reduction of about 9%[22]

| 主要产品 | 2023 年 1-9 月平均 | 2022 年 1-9 月平均 | 同比增减（%） | | --- | --- | --- | --- | | | 售价（万元/吨） | 售价（万元/吨） | | | 氨基甲酸酯类 | 9.44 | 10.57 | -10.67 | | 杂环类 | 8.93 | 13.13 | -31.95 | | 有机磷类 | 19.02 | 19.42 | -2.07 | | 剂型类 | 3.89 | 3.31 | 17.37 | | 锂电材料类 | 10.49 | 11.57 | -9.37 | 2、主要原材料的价格变动情况（不含税） | 主要产品 | 2023 年 | 1-9 | 月产量 | 2023 年 | 1-9 | 月销量 | 2023 | 年 | 1-9 | 月销售 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | （吨） | | | （吨） | | | 金额（万元） | | | | | 氨基甲酸酯类 | 6,903.13 | | | 5,138.45 | | | ...

一、监事会会议召开情况 湖南海利化工股份有限公司第十届六次监事会会议于 2023 年 10 月 17 日以 书面、传真和电子邮件的方式发出会议通知，于 2023 年 10 月 27 日上午在长沙 市公司本部采用现场方式召开。会议应到监事 3 人，实到监事 3 人，会议由监事 会主席李一辉先生主持。会议的召集、召开和表决程序符合《公司法》和《公司 章程》的规定。 二、监事会会议审议情况 与会监事经认真讨论并以记名投票方式表决，审议通过以下决议： （一）审议通过了《公司2023年第三季度报告》。 表决情况：同意 3 票；弃权 0 票；反对 0 票。 证券代码：600731 证券简称：湖南海利 公告编号： 2023－039 湖南海利化工股份有限公司 第十届六次监事会决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 关联监事刘晚苟先生回避表决。 监事会认为： 监事会认为： 1、《公司 2023 年第三季度报告》编制和审议程序符合法律、法规、公司章 程和公司内部管理制度的各项规定； 2、《公司 2023 年第三季度报告》的内容和 ...

证券代码：600731 证券简称：湖南海利 公告编号：2023-041 湖南海利化工股份有限公司 关于全资子公司海利株洲公司关停事项确认资产处置 收益的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、本次确认资产处置收益概述 湖南海利化工股份有限公司（以下简称"公司"）全资子公司湖南海利株洲 精细化工有限公司（以下简称"海利株洲"）为认真贯彻落实《湖南省湘江保护 和治理第二个"三年行动计划"（2016-2018年）实施方案》（湘政办发【2016】 26号和《株洲市2017年两型社会建设综合配套改革工作计划》等文件的精神，按 照整体关停退出安排，遵照公司第八届十三次董事会决议，于2017年6月30日实 施全面关停。详见《湖南海利化工股份有限公司关于全资子公司湖南海利株洲精 细化工有限公司关停退出的公告》（公告编号：2017－021）。 公司于2023年10月27日召开第十届董事会九次会议、第十届监事会六次会议， 审议通过了《关于全资子公司海利株洲公司关停事项确认资产处置收益的议案》， 同意公司全资子公司海利株洲公司关停 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 证券代码：600731 证券简称：湖南海利 公告编号：2023－038 湖南海利化工股份有限公司 第十届九次董事会决议公告 （一）审议通过了《公司2023年第三季度报告》； 特此公告。 表决情况：同意9票；弃权0票；反对0票。 《公司 2023 年 第 三 季 度 报 告 》 具 体 内 容 详 见 上 海 证 券 交 易 所 网 站 （http://www.sse.com.cn）上同日公告。 湖南海利化工股份有限公司董事会 2023年10月31日 湖南海利化工股份有限公司第十届九次董事会会议于2023年10月17日以书 面、传真和电子邮件的方式发出会议通知，于2023年10月27日上午在长沙市公司 本部会议室采用现场和通讯表决方式召开，会议应到董事9人，实到董事9人。会 议由刘卫东先生主持，会议的召集、召开和表决程序符合《公司法》和《公司章 程》的规定。 二、董事会会议审议情况 （二）审议通过了《关于全资子公司海利株洲公司关停事项确认资产处置收 益的议案 ...

湖南海利化工股份有限公司独立董事 关于全资子公司海利株洲公司关停事项确认资产处置收益 的独立意见 根据《中华人民共和国公司法》、《中华人民共和国证券法》、《上 海证券交易所股票上市规则》、《上市公司治理准则》、《上市公司独立 董事规则》以及《湖南海利化工股份有限公司章程》、《独立董事制度》 的相关规定，作为公司独立董事，基于独立判断的原则，对公司第十 届董事会九次会议审议的《关于全资子公司海利株洲公司关停事项确 认资产处置收益的议案》内容发表如下独立意见： 我们认为：公司本次全资子公司海利株洲公司关停事项确认资产 处置收益符合《企业会计准则》和公司相关会计处理的规定，确认方 法和金额能够客观、公允的反映公司的财务状况和经营成果，不存在 损害公司及全体股东，特别是中小投资者利益的情形。本次海利株洲 公司关停事项确认资产处置收益的决策程序符合相关法律、法规及 《公司章程》等有关规定，同意公司本次海利株洲公司关停事项确认 资产处置收益事项。 独立董事（签字）： 罗和安 谭燕芝 朱开悉 2023 年 10 月 27 日 ...

证券代码：600731 证券简称：湖南海利 公告编号：2023-037 湖南海利化工股份有限公司 关于参加2023年湖南辖区上市公司投资者 网上集体接待日活动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 为进一步加强与投资者的互动交流，湖南海利化工股份有限公司（以下简称 “公司”）将参加由湖南证监局、湖南省上市公司协会与深圳市全景网络有限公 司联合举办的“推动上市公司规范运作，保护中小投资者——2023 年湖南辖区 上市公司投资者网上集体接待日”活动，现将相关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录“全景路演”网站 （https://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP, 参与本次互动交流，活动时间为 2023 年 11 月 2 日（星期四）14:00-17:00。届 时公司高管将在线就公司 2023 年度三季度报告、公司治理、发展战略、经营状 况、融资计划、股权激励和可持续发展等投资者关心的问题，与投资者进行沟通 与交流，欢迎广大投资者踊跃参与！ ...

证券代码：600731 证券简称：湖南海利 公告编号：2023-036 湖南海利化工股份有限公司 关于召开 2023 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2023 年 10 月 09 日(星期一) 下午 16:00-17:00 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2023 年 09 月 22 日(星期五)至 09 月 28 日(星期四)16:00 前 登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 sh600731@sina.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行 回答。 湖南海利化工股份有限公司（以下简称"公司"）已于 2023 年 8 月 29 日发 布公司 2023 年半年度报告，为便于广大投资者更全面深入地了解公司 2023 年半 年度经营成果、财务 ...

Financial Performance - The company's operating revenue for the first half of 2023 was approximately ¥1.23 billion, a decrease of 14% compared to the same period last year[20]. - The net profit attributable to shareholders of the listed company was approximately ¥163 million, down 11.01% year-on-year[20]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was approximately ¥157 million, a decrease of 9.19% compared to the previous year[20]. - Basic earnings per share decreased by 24.26% to CNY 0.3006 compared to the same period last year[21]. - Weighted average return on equity dropped to 6.04%, a decrease of 4.08 percentage points year-on-year[21]. - The company achieved a revenue of 1.234 billion yuan in the reporting period, a year-on-year decrease of 14%, and a net profit attributable to the parent company of 163 million yuan, down 11.01% year-on-year[39]. - Total operating revenue for the first half of 2023 was CNY 1,233,549,986.99, a decrease of 14.0% compared to the previous year[45]. - The company reported a net profit of CNY 578,806,619.63 for the first half of 2023, compared to CNY 324,375,275.96 in the same period of 2022, an increase of 78.7%[164]. Cash Flow and Assets - The net cash flow from operating activities was approximately ¥310 million, showing a significant improvement from a negative cash flow in the previous year[20]. - The net cash flow from operating activities improved significantly to 309,602,520.88 RMB, compared to a negative cash flow of 44,053,506.57 RMB in the previous year[46]. - The company reported a significant increase in cash and cash equivalents, which accounted for 29.67% of total assets, up from 19.60% in the previous year[49]. - The total assets at the end of the reporting period reached approximately ¥4.48 billion, an increase of 14.09% compared to the end of the previous year[20]. - The company's current assets reached CNY 2,598,637,201.97, up from CNY 2,145,278,210.14, indicating an increase of about 21.1% year-over-year[156]. - Cash and cash equivalents stood at CNY 1,328,823,029.58, compared to CNY 769,342,388.41 at the end of 2022, reflecting a significant increase of approximately 72.5%[156]. Investments and R&D - The company plans to enhance R&D investment to improve technology and product quality, aiming for better operational performance[33]. - The company has designed and synthesized 114 new chemical compounds, including 48 with A-level insecticidal and acaricidal activity, and 22 with A-level fungicidal activity[43]. - Research and development expenses for the first half of 2023 were CNY 66,714,746.37, slightly down from CNY 67,895,836.47 in the first half of 2022[166]. - The company is focusing on enhancing its technological capabilities through ongoing research and development efforts[192]. Market Conditions and Risks - The global pesticide market faced significant challenges, leading to a decline in product prices and overall market volume[32]. - The agricultural chemical industry is experiencing slow recovery, with internal demand insufficient and competition intensifying[32]. - The company faces risks from potential changes in agricultural chemical industry policies, which may tighten production access and increase regulatory scrutiny[59]. - Environmental protection policy changes pose a risk, as stricter standards could lead to increased operational costs and potential penalties for non-compliance[60]. - The company is exposed to market competition risks due to the fragmented nature of the agricultural chemical industry in China[62]. Shareholder and Capital Management - The company did not propose any profit distribution plan or capital reserve transfer to increase share capital during this reporting period[4]. - The company announced a profit distribution plan for the first half of 2023, indicating no distribution or capital reserve increase is applicable[83]. - The company approved a cash dividend of CNY 0.04 per share and a bonus share distribution of 0.2 shares for every share held, with a capital reserve increase of 0.1 shares per share, based on a total share capital of 355,222,698 shares[86]. - The total capital reserve at the end of the period was 615,503,293.91, which supports the company's strategic initiatives[196]. Environmental and Social Responsibility - The company has established an ISO14001 environmental management system and has purchased environmental pollution liability insurance for the period from April 28, 2023, to April 27, 2024[99]. - The company has implemented measures to reduce carbon emissions, focusing on energy recovery and resource utilization, which has led to a decrease in pollutant emissions[101]. - The company provided 300,000 yuan in special funds to support rural revitalization efforts in Hunan province[102]. - The company has completed environmental impact assessments for all construction projects, which have been approved by local environmental authorities[94]. Legal and Compliance - There were no significant lawsuits or arbitration matters during the reporting period, indicating a stable legal environment for the company[111]. - The company has not reported any non-standard audit opinions in its annual report, indicating a clean financial audit[111]. - The company has no significant related party transactions that have not been disclosed in temporary announcements, indicating transparency in its operations[113].

一、募集资金基本情况 （一）实际募集资金金额及资金到位时间 经中国证券监督管理委员会《关于核准湖南海利化工股份有限公司非公开发 行股票的批复》（证监许可〔2022〕2671 号）的核准，公司以非公开发行方式 发行人民币普通股（A 股）股票 96,952,908 股，每股面值 1.00 元，每股发行价 格为人民币 7.22 元，募集资金总额为人民币 699,999,995.76 元，扣除发行费用人 民币 14,155,615.89 元（不含增值税 ） 后，实际募集资 金 净额为人民币 685,844,379.87 元。上述资金已于 2023 年 1 月 17 日到位，大华会计师事务所（特 殊普通合伙）已对募集资金到位情况进行了审验，并出具了大华验字 [2023]000044 号《验资报告》。 （二）报告期募集资金使用和结余情况 证券代码：600731 证券简称：湖南海利 公告编号： 2023－034 湖南海利化工股份有限公司 关于 2023 年半年度募集资金存放与实际使用情况 的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律 ...